Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/20/2021 13 0
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Jan/06/2021 8 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Dec/17/2020 7 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/11/2020 7 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/04/2020 2 2
EIDD-2801 Potential treatment - pre-clinical evidence Experimental Antiviral Dec/03/2020 1 0
mRNA-1273 Emergency use authorization Experimental Vaccine Dec/03/2020 4 0
Leporin A Potential treatment - theoretical effect Natural product Antiviral Dec/02/2020 1 0
3,3-Dimethyl-N-[4-(piperidin-1-ylcarbonyl)phenyl]butanamide Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020 1 0